Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Equity (2016 - 2025)

BioCorRx's Return on Equity history spans 15 years, with the latest figure at 18.1% for Q3 2025.

  • For Q3 2025, Return on Equity rose 1767.0% year-over-year to 18.1%; the TTM value through Sep 2025 reached 18.1%, up 1767.0%, while the annual FY2024 figure was 4.34%, 865.0% up from the prior year.
  • Return on Equity for Q3 2025 was 18.1% at BioCorRx, up from 0.4% in the prior quarter.
  • Across five years, Return on Equity topped out at 18.1% in Q3 2025 and bottomed at 10.9% in Q4 2023.
  • The 5-year median for Return on Equity is 0.6% (2022), against an average of 2.21%.
  • The largest annual shift saw Return on Equity plummeted -1146bps in 2023 before it soared 1767bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.82% in 2021, then tumbled by -30bps to 0.57% in 2022, then tumbled by -2017bps to 10.9% in 2023, then skyrocketed by 104bps to 0.43% in 2024, then skyrocketed by 4128bps to 18.1% in 2025.
  • Per Business Quant, the three most recent readings for BICX's Return on Equity are 18.1% (Q3 2025), 0.4% (Q2 2025), and 17.43% (Q1 2025).